Fig. 1 | British Journal of Cancer

Fig. 1

From: Expert recommendations on the management of hypertension in patients with ovarian and cervical cancer receiving bevacizumab in the UK

Fig. 1

Management of hypertension before and during bevacizumab therapy. aABPM/HBPM recorded over at least 4 consecutive days. bIf there is a marked difference between clinic BP and ABPM/HBPM (i.e., >20/10 mmHg), the latter should be repeated with a treatment target of <150/95 mmHg. ABPM ambulatory blood pressure monitoring, BP blood pressure, HBPM home blood pressure monitoring, n/a not applicable, NICE National Institute for Health and Care Excellence

Back to article page